Corporate Counsel Litigation Forum: Strategies & Trends in Effective Value-Based Billing
Webinar | 06.23.15, 10:00 AM EDT - 11:00 AM EDT
Please click here for a copy of the presentation.
For in-house counsel only, Crowell & Moring panelists and pricing experts will discuss "business of the law" trends in value-based billing (VBB) arrangements and their priorities and goals for dealing with those trends in 2015.
The panel will take questions and engage participants in a discussion of at least the following topics:
- What types of value-based billing arrangements are we seeing in hiring outside counsel? Which arrangements are working best?
- How are law firms meeting client needs in these areas and delivering value? What else can be done?
- What are the challenges and how are they being overcome?
Panelists:
- Robert A. Lipstein, Crowell & Moring Senior Counsel
- Dr. Silvia Hodges Silverstein, Executive Director and Founder of the Buying Legal Council
- Justin Ergler, Director of Alternative Fee Intelligence and Analytics at GlaxoSmithKline
- Matthew Laws, Crowell & Moring Sr. Director of Practice Management
Moderator:
Jerry Murphy, Crowell & Moring Partner
We hope you are able to join us for this webinar.
Click for more on Crowell & Moring's Corporate Counsel Litigation Forum webinar series.
Click to download our Handbook for Value-Based Billing Engagements [PDF].
For more information, please visit these areas: Intellectual Property Litigation, Product Risk Management, Government Contracts , Environment and Natural Resources, Insurance / Reinsurance, International Trade, International Dispute Resolution, Tax, Labor and Employment, Corporate and Transactional, Litigation and Trial, Intellectual Property, Corporate Counseling, Governance and Compliance
Insights
Webinar | 10.16.25
The landscape of AI governance and regulation is shifting. Following the release of the White House’s “America’s AI Action Plan” in July 2025 and the President’s signing of related Executive Orders, the White House has emphasized (at least rhetorically) a preference for innovation, adoption, and deregulation. But that does not tell the entire story. The Administration remains committed to exercising a heavy hand in AI, including by banning the U.S. government’s procurement of so-called “woke AI,” intervening in the development of data centers and the export of the AI technology stack, imposing an export fee for certain semiconductors to China, and assuming a stake in a U.S. semiconductor company. State legislatures are also racing to implement their own regulations, particularly around AI’s use in critical areas, such as healthcare, labor and employment, and data privacy. The many sources of regulation raise the specter of a fragmented compliance environment for businesses. This webinar will delve into the Administration’s AI strategy, going beyond the headlines to analyze:
Webinar | 09.29.25
False Claims Act and Customs Enforcement—What You Need to Know
Webinar | 09.25.25
